Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1751-1760 of 2919 for cancer

Edit search filters
  1. Ponatinib Hydrochloride In Treating Patients With Advanced Biliary Cancer With FGFR2 Fusions

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. Offering HPV Self-Collection In Novel Healthcare Settings To Improve Uptake Of Cervical Cancer Screening

    Rochester, MN

  3. Study Of Pembrolizumab (MK-3475) In Participants With Advanced Urothelial Cancer (MK-3475-052/KEYNOTE-52)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. Phase 1 Study Of CLR 125 In Triple Negative Breast Cancer

    Jacksonville, FL, Rochester, MN

  5. Hypofractionated Radiation Therapy In Treating Participants With Prostate Cancer High-Risk Features Following Radical Prostatectomy

    Scottsdale/Phoenix, AZ, Rochester, MN

  6. Study Of Sacituzumab Govitecan (IMMU-132) In Metastatic Or Locally Advanced Unresectable Urothelial Cancer

    Scottsdale/Phoenix, AZ

  7. A First-in-Human Study Of MEN2501 In Participants With Platinum-Resistant Ovarian Cancer

    Rochester, MN

  8. Expanded Access Study Of TAS-102 In Patients With Metastatic Colorectal Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  9. BPM31510 Administered Intravenously With Or Without Gemcitabine In Advanced Pancreatic Cancer Patients

    Scottsdale/Phoenix, AZ

  10. A Study Of AbGn-107 In Patients With Gastric, Colorectal, Or Pancreatic Cancer

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer